TLR4 inhibition delayed disease progression, attenuated spinal cord astroglial and microglial reaction, and reduced spinal motor neuron loss in the ALS hSOD1G93A mouse model. This evidence concerns the gene TLR4 and amyotrophic lateral sclerosis.